Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658–62)

Detalles Bibliográficos
Autor principal: Kawada, Tomoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353571/
https://www.ncbi.nlm.nih.gov/pubmed/35929175
http://dx.doi.org/10.4093/dmj.2022.0131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353571/
https://www.ncbi.nlm.nih.gov/pubmed/35929175
http://dx.doi.org/10.4093/dmj.2022.0131

Ejemplares similares